Filter posts

Biotech Could Miss a Multi-Billion Dollar Opportunity in Rare Disease

Drug development is expensive.  Drug development is risky.  Drug development takes a long time. The …

Op-Ed: As I Lay Dying

Former staff writer for the LA Times Laurie Becklund shares her experience ‘climbing ladders and …

Know Any Biotech Superheroes?

Every day, countless men and women are working tirelessly to heal, fuel and feed the …

Seizing Academic Breakthroughs in Japan

Japanese universities and universities around the Asia Pacific region are entering into unique evolving partnerships …

Paying the Price for Poorly Harmonized Regulations Around GM Crops

At the beginning of December 2014, the Genetic Literacy Project launched a 6-part series to …

World Rare Disease Day Celebrates Patient Advocacy and Activism Around The Globe

Global Genes™ and the identifiable Blue Denim Genes Ribbon™ provides opportunity to show support and …